Analyst Ratings for Akcea Therapeutics, Inc. (AKCA) [Buys]

AKCA Rating Summary

AKCA Price Target Summary

* Over Last 12-Mos
  |   Expand Research on AKCA
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $18.15 (-0.1%) * Over Last 12-Mos
Rating Score: 2 / 10   Percentile Rank: 36%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
9/18/2018 Needham & Company
» Updated 10/7/2019
Chad Messer New Coverage Buy
(N/A)
45.00
(N/A)
24.16
(18.17)
-24.79% Details
Like AKCA Ratings? Also take a look at IONS, BLDR, RST, VRTU

AKCA Ratings News